New York State Common Retirement Fund Avenue Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$1.48 - $2.65 $88 - $159	-60 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$2.41 - $7.11 $16,243 - $47,921	-6,740 Reduced 99.12%	60 $0
Q3 2020 Nov 05, 2020	SELL	$9.37 - $12.06 $20,614 - $26,532	-2,200 Reduced 24.44%	6,800 $74,000
Q2 2020 Aug 07, 2020	BUY	$8.29 - $11.47 $74,609 - $103,230	9,000 New	9,000 $97,000

Ticker ATXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,127,720
Market Cap $13.8M
Description
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.